Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.

Autor: Alsalawy NF; Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., Darwish RK; Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., Kamal MM; Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., ElTaweel AE; Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., Shousha HI; Department of Endemic Hepatogastroenterolog, Faculty of Medicine, Cairo University, Cairo, Egypt., Elbaz TM; Department of Endemic Hepatogastroenterolog, Faculty of Medicine, Cairo University, Cairo, Egypt.

Publikováno v: Journal of medical virology [J Med Virol] 2018 Mar; Vol. 90 (3), pp. 490-496. Date of Electronic Publication: 2017 Oct 20.